EMLW AESTHETICS LTD
Company number 13516453 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
EMLW AESTHETICS LTD - Analysis Report
Company Number: 13516453
Analysis Date: 2025-07-20 12:42 UTC
Financial Health Assessment for EMLW AESTHETICS LTD
1. Financial Health Score: D
Explanation:
The company exhibits persistent net current liabilities and net negative equity over multiple years, indicating financial distress. While still active and compliant with filings, the company's balance sheet shows symptoms akin to a patient with chronic liquidity issues and undercapitalization. Without intervention, this condition could worsen.
2. Key Vital Signs (Critical Metrics & Interpretation):
| Metric | 2024 (£) | 2023 (£) | 2022 (£) | 2021 (£) | Interpretation |
|---|---|---|---|---|---|
| Current Assets | 5 | 11 | 11 | 2 | Extremely low cash or receivables; "starved" |
| Current Liabilities | 4,089 | 3,646 | 3,646 | 2,505 | High short-term debts relative to assets |
| Net Current Assets | -4,084 | -3,635 | -3,635 | -2,503 | Negative working capital - liquidity distress |
| Net Assets (Equity) | -4,084 | -3,635 | -3,635 | -2,503 | Negative net worth - "balance sheet anemia" |
| Shareholders’ Funds | -4,084 | -3,635 | -3,635 | -2,503 | Owner’s stake is eroded, signaling losses |
| Average Employees | 1 | 1 | - | - | Small scale, limited human resources |
- Liquidity concerns: The company’s current liabilities vastly exceed its current assets, which is a red flag for cash flow problems. This "symptom" means the company may struggle to meet short-term obligations, risking operational disruption.
- Solvency concerns: Negative net assets over four consecutive years indicate accumulated losses or undercapitalization, reflecting deeper financial malaise.
- Scale: Micro-entity classification confirms the business is very small, with limited resources to absorb shocks.
3. Diagnosis: Overall Financial Condition
EMLW AESTHETICS LTD is exhibiting chronic financial stress characterized by persistent negative working capital and negative equity. This condition can be likened to a patient with a weak immune system struggling to sustain normal functions. The company’s financial "vital signs" reveal it has been operating at a loss or with insufficient capital since incorporation. While no insolvency proceedings are currently underway, the balance sheet indicates a fragile financial state that limits growth potential and increases vulnerability to external shocks.
The fact that the director is also the sole significant controller and the only employee suggests reliance on a very narrow operational base, which can exacerbate risk exposure.
4. Recommendations: Steps to Improve Financial Wellness
a. Improve Liquidity:
- Consider negotiating extended payment terms with creditors to ease immediate cash flow pressure.
- Accelerate collection of any receivables or generate cash through sales or other means.
b. Capital Injection:
- Inject fresh equity capital or seek external investment to replenish shareholders’ funds and improve net assets.
- Alternatively, the director may consider a shareholder loan to support operations temporarily.
c. Cost Control & Revenue Growth:
- Review and reduce discretionary expenses to conserve cash.
- Explore opportunities to increase client base or service offerings within the beauty treatment sector to improve turnover.
d. Financial Monitoring:
- Implement more rigorous cash flow forecasting to anticipate liquidity issues and manage working capital proactively.
e. Professional Advice:
- Engage with an accountant or financial advisor to develop a turnaround plan and consider restructuring options if losses continue.
Medical Analogy Summary:
EMLW AESTHETICS LTD is currently showing "symptoms" of financial distress — akin to a patient with low blood pressure and anemia. Without timely intervention to restore liquidity and capital, the company risks entering a critical state that could lead to insolvency—a condition analogous to organ failure. However, the company remains "alive" and can recover if it follows a disciplined regimen of financial management and capital support.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.